Correlation Between Trio Tech and CERo Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Trio Tech and CERo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Trio Tech and CERo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Trio Tech International and CERo Therapeutics Holdings, you can compare the effects of market volatilities on Trio Tech and CERo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Trio Tech with a short position of CERo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Trio Tech and CERo Therapeutics.

Diversification Opportunities for Trio Tech and CERo Therapeutics

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between Trio and CERo is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Trio Tech International and CERo Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CERo Therapeutics and Trio Tech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Trio Tech International are associated (or correlated) with CERo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CERo Therapeutics has no effect on the direction of Trio Tech i.e., Trio Tech and CERo Therapeutics go up and down completely randomly.

Pair Corralation between Trio Tech and CERo Therapeutics

Considering the 90-day investment horizon Trio Tech International is expected to under-perform the CERo Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Trio Tech International is 12.7 times less risky than CERo Therapeutics. The stock trades about -0.23 of its potential returns per unit of risk. The CERo Therapeutics Holdings is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  2.00  in CERo Therapeutics Holdings on September 23, 2024 and sell it today you would lose (1.10) from holding CERo Therapeutics Holdings or give up 55.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Trio Tech International  vs.  CERo Therapeutics Holdings

 Performance 
       Timeline  
Trio Tech International 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Trio Tech International are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Trio Tech unveiled solid returns over the last few months and may actually be approaching a breakup point.
CERo Therapeutics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in CERo Therapeutics Holdings are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, CERo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Trio Tech and CERo Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Trio Tech and CERo Therapeutics

The main advantage of trading using opposite Trio Tech and CERo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Trio Tech position performs unexpectedly, CERo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CERo Therapeutics will offset losses from the drop in CERo Therapeutics' long position.
The idea behind Trio Tech International and CERo Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas